Abstract
Cryptococcosis is currently the most common life threatening mycoses found in patients with the acquired immunodeficiency syndrome (AIDS). Extrapulmonary involvement is most frequently seen, especially in the central nervous system and skin. Clinical findings are non-specific, even in patients with meningitis. Threshold for diagnosis of this infection should be low, with serum cryptococcal antigens, blood, urine and sputum cultures for Cryptococcus neoformans performed in febrile AIDS patients. Lumbar puncture should also be performed if unexplained headaches are included in a patient's complaints. There is currently no consensus for the most appropriate treatment strategy and the role of oral azoles versus amphotericin B or amphotericin B with flucytosine remains a serious question in need of further controlled studies. Patients eligible for multicentered trials should be encouraged to participate. Therapy for others should be individualized. This review will address some of these issues.
Similar content being viewed by others
References
Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the aquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 234–40.
Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the aquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 533–8.
Dismukes WE. Cryptococcal meningitis in patients with AIDS. J of Infect Dis 1988; 157: 624–8.
Anonymous. Cryptococcosis and AIDS. Lancet 1988; i: 1434–6.
Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. New Engl J Med 1989; 321: 794–9.
Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 1990; 12: 768–78.
Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gatti. J Clin Micro 1990; 28: 1642–4.
Clancy MN, Fleischmann J, Howard DH, Kwon-Chung KJ, Shimizu RY. Isolation of Cryptococcus neoformans gattii from a patient with AIDS in southern California (letter). J Infect Dis 1990; 161: 809.
Bottone EJ, Toma M, Johansson BE. Poorly encapsulated Cryptococcus neoformans from patients with AIDS: I. Preliminary observations. AIDS Res 1986; 2: 211–8.
Larsen RA, Bozzette S, McCutchan JA, et al. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann Intern Med 1989; 111: 125–8.
Bennett JE, Dismukes WE, Duma RJ. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New Engl J Med 1979; 301: 126–31.
Sugar AM, Stern JJ, Dupont B. Overview: Treatment of cryptococcal meningitis. Rev Infect Dis 1990; 12: S338–48.
Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. New Engl J Med 1987; 317: 334–41.
Galgiani JN. Fluconazole, a new antifungal agent. Ann Intern Med 1990; 113: 177–9.
Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med 1990; 113: 183–7.
Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA. Itraconazole therapy for cryptococcal meningitis and Cryptococcosis. Arch Intern Med 1989; 149: 2301–8.
Bozzette SA, Larsen R, Chiu J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. New Eng J Med 1991; 324: 580–4.
Sugar AM, Saunders C. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 481–9.
Stern JJ, Hartman BJ, Sharkey P, et al. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptcoccosis: experience with 22 patients. Am J Med 1988; 85: 477–80.
Powderly W, Saag M, Cloud G, et al. Fluconazole (FLU) versus amphotericin B (AMB) as maintenance therapy for prevention of relapse of AIDS-associated cryptococcal meningitis (CM). Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy 1990: #1162.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sugar, A.M. Overview: Cryptococcosis in the patient with AIDS. Mycopathologia 114, 153–157 (1991). https://doi.org/10.1007/BF00437205
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00437205